Ventricular Shunt Procedures with MCC DRG Reimbursement

DRG 031 encompasses ventricular shunt procedures with Major Complication or Comorbidity and captures cases with elevated clinical complexity requiring more resources. Correct classification affects inpatient reimbursement under Medicare by aligning payment with expected increased resource use for complex neurosurgical and medical management.

DRG 031 Overview

DRG 031 covers inpatient hospital admissions for ventricular shunt procedures with Major Complication or Comorbidity, typically performed to treat hydrocephalus or cerebrospinal fluid diversion issues complicated by serious comorbid conditions. This Diagnosis-Related Group groups cases with higher resource use due to the need for complex operative management, intensive monitoring, and potential management of significant medical complications. It matters for Medicare payment because classification into this Diagnosis-Related Group results in higher reimbursement relative to less severe groupings, reflecting increased expected costs of care.

DRG 031 Overview

Acute surgical management and perioperative complication reduction studies: randomized or prospective cohorts testing protocols to reduce intraoperative and early postoperative complications in patients undergoing ventricular shunt placement or revision for hydrocephalus with major comorbidities. These studies focus on adults and children admitted for primary shunt insertion or revision when there is an associated major complication (for example infection, hemorrhage, or organ failure), evaluating interventions such as optimized perioperative antibiotic strategies, intraoperative monitoring bundles, or cerebrospinal fluid handling protocols. Results are highly relevant to hospitals and payers because reducing early complications drives shorter length of stay, fewer return-to-OR events, and lower inpatient costs for cases captured by this MCC-level DRG.
Comparative effectiveness trials of shunt technologies and surgical approaches in high-risk patients: pragmatic trials or registry-based comparative studies that compare different valve designs, programmable versus fixed-pressure systems, or endoscopic versus open shunt techniques specifically in patients with complex clinical histories (for example prior infections, multiple revisions, or significant organ dysfunction). These studies enroll the DRG population with major complications to assess device durability, revision rates, infection incidence, and functional outcomes over months to years, helping clinicians choose options that minimize readmissions and reoperations. Payers and health systems use these data to inform procurement, bundle payments, and to predict long-term resource utilization associated with recurrent admissions under this DRG.
Post-discharge outcomes and care coordination research targeting readmission prevention and rehabilitation: observational cohorts and interventional trials of transition-of-care programs, home monitoring of shunt function, and targeted rehabilitation or infection surveillance in patients discharged after a shunt procedure complicated by a major comorbidity. These studies examine outcomes such as 30- and 90-day readmission rates, emergency department revisits for shunt failure or infection, functional status, and cost-effectiveness of post-acute services in a population at high risk for recurrent inpatient care. Findings inform discharge planning, outpatient follow-up intensity, and payer-covered post-acute services that can reduce costly repeat admissions and improve long-term outcomes for the DRG cohort.

Acute surgical management and perioperative complication reduction studies: randomized or prospective cohorts testing protocols to reduce intraoperative and early postoperative complications in patients undergoing ventricular shunt placement or revision for hydrocephalus with major comorbidities. These studies focus on adults and children admitted for primary shunt insertion or revision when there is an associated major complication (for example infection, hemorrhage, or organ failure), evaluating interventions such as optimized perioperative antibiotic strategies, intraoperative monitoring bundles, or cerebrospinal fluid handling protocols. Results are highly relevant to hospitals and payers because reducing early complications drives shorter length of stay, fewer return-to-OR events, and lower inpatient costs for cases captured by this MCC-level DRG.
Comparative effectiveness trials of shunt technologies and surgical approaches in high-risk patients: pragmatic trials or registry-based comparative studies that compare different valve designs, programmable versus fixed-pressure systems, or endoscopic versus open shunt techniques specifically in patients with complex clinical histories (for example prior infections, multiple revisions, or significant organ dysfunction). These studies enroll the DRG population with major complications to assess device durability, revision rates, infection incidence, and functional outcomes over months to years, helping clinicians choose options that minimize readmissions and reoperations. Payers and health systems use these data to inform procurement, bundle payments, and to predict long-term resource utilization associated with recurrent admissions under this DRG.
Post-discharge outcomes and care coordination research targeting readmission prevention and rehabilitation: observational cohorts and interventional trials of transition-of-care programs, home monitoring of shunt function, and targeted rehabilitation or infection surveillance in patients discharged after a shunt procedure complicated by a major comorbidity. These studies examine outcomes such as 30- and 90-day readmission rates, emergency department revisits for shunt failure or infection, functional status, and cost-effectiveness of post-acute services in a population at high risk for recurrent inpatient care. Findings inform discharge planning, outpatient follow-up intensity, and payer-covered post-acute services that can reduce costly repeat admissions and improve long-term outcomes for the DRG cohort.

OpenPayer

Ventricular Shunt Procedures with MCC: Inpatient Reimbursement Overview

Sign up for drg 031 policy alerts

DRG 031 Overview

OpenPayer

Ventricular Shunt Procedures with MCC: Inpatient Reimbursement Overview

Sign up for drg 031 policy alerts

DRG 031 Overview

Clinical Trials

Related Codes

References

Clinical Trials

Related Codes

References